# Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist

> **Open Intelligence Dossier** · First detected: 2026-10-29 16:40 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist" is generating significant coverage in the Business category, with 6 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance, Trefis, Seeking Alpha and Investing.com. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Seeking Alpha | Iovance plummets on new phase 2 Amtagvi data for non-small-cell lung cancer | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxObzJwaVI1OWk3RHUySEM5aFNnSnhBMjUzWnJhWmJJRmJuVndzVWNiQTRZeUNJeWNiR1pPaG9YN25jZVJ2WG9aQkYwdU1lZE5yMUlnQUFsZDczdlpKX3p6SExqU19ZS2RIMEZGZENqNE1GVU12cVhPeTlSdEdWeGE0bWFHWFNZUldYVlVoWTJwYlA1VVc2UWdwRE1MaXU5SnJXS0h1SjBVdWRoUQ?oc=5) |
| Yahoo Finance | Melanoma Trial Results Could Be A Game Changer For Iovance Biotherapeutics (IOVA) | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxOSlVDeHJBQ1B6aHBwRVU3VEl4Z3lDZGFTSk02OEMyTkNiWkRFTzlXamFPMUZfVnkzbzBPcTdNYnhLZThqVFJwc3duY01xS1diVXlJbnA1Q3dadmVqQzRnMW9haEw3YlZTa1dXM2JFeC15akYtVTN5enUxV1VZczhxMFFfR0tCSEFVUTdsODJEczh1VWNGT3RGTUVn?oc=5) |
| TradingView | Why Did IOVA Stock Jump Over 10% After-Hours Today? | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxPdWtqZ2RMZ1lybV9SSzQ4bER2cjNmYVZfeE1SUlVsOFJENE96VkdJMElJekdNSTFIeGZBY1BJVm5pUnNYSF9WQU1vSTliYW9Pb3VZNnpmbEs0a0R5aVNCUHRHdWhfNVRua3NweURadFl5SFp0dzR4a1hYcU00RTJWcnlrNGgxVTEzdUFDRWpWNVNHUjhrOUJXYTdXbjAySlNzMXRDRWlDckhrSjJyTWVj?oc=5) |
| Yahoo Finance | Why Did IOVA Stock Jump Over 10% After-Hours Today? | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxOQ2lpUUQzYTJNM2p3blJBeXA0MW90TXpNWG0wejFJa181ZFdSZjBHWXA4NW1vbEljVUc1ZGZqbE9sNFEwUGM2cjBoRkh0VllpQ2dVRGxwd2ZVS1l1bHBwdFprRVlUQXNDQjF5cUxhTjE0Y05iX1QySC1BeTNkMDlseS1GckJTdFpvMWRUTWxvSHhBUQ?oc=5) |
| Yahoo Finance | Iovance stock falls after lung cancer trial data disappoints | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxQRU1JbjI2RkZRckQyVTR0TXJ0UFJ2WU9qQmxTY3kzd1JCYmNVakJIeVdxTG9NcVdDUGRhUkhQLUIyaUNmLUJXMUVPS0hOTlU1NlVYbTNBMGY3UUhYZzRhcUltTkdyY0Zyc0ZTNUREUndCSXRLemMxQnhLbWxmbkc1Q0cyQ0l0ZjJPUHhyWlA1QnRTaGhqSFFnQ3VfWVg?oc=5) |
| Trefis | Can Iovance Stock Fall 50%? | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxPWGhXUlFlRTIzRzZlcUZKOVJ0QkwxV1ZCSG1TS2hvZEwzSHhEUmc3XzNzWG9SUjBjUGoxRlVjWmVKWUlQRWE4RmxzQ1BmaTRCbHJKNk4zWWx6UW9hZW1ScUZjRnlVRGR0dk9uX3VtNFZHV290eGZCQ1hMUUd4d09HRFNvdUxMc19IbEtaeWJiRQ?oc=5) |
| Seeking Alpha | Iovance sees long-term response for Amtagvi in first-line melanoma (IOVA:NASDAQ) | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxPNWVpLW5nRWMtVVpDSmoyektEcWtrUE0tdFB2SFRKUmc5bW90eGpGYjBwRUFBVTk4NGRadXNkQm5lNVludFBUSHBWbGF6MnNHQk5yTzV6U0dZMXo4SEQwSFRPY3VJbTQ5V3BzNDdjRXliellfTDFkR1k5ZE5qd0RBRlJKUU1qQ3d0LUJ0ai1qU0pLVnoxMms1a2p0QzJ0UQ?oc=5) |
| Investing.com | Why is Iovance Biotherapeutics stock sliding today? | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxONWJReEREVEdIeXlFYmszVTUycGw5MkJoVDhTZ0IzenlITmM2cVExQjF0d0x0RXNfR0VKbF84LUlCZHlvQ0tSY3luN2pCaHgzQ29tYmdBak9BU1ptRGNtcHVBbzRXM1Z2YUFjd1cxMlRZNXdMMjdSZFFJc3o5eDdLYmRTYjZoRnRndS1LRDQ5Y214NTQ0N0p6dWhWTHdWSk1uMXJRM00xR1Y3R2xDWDFMdGRB?oc=5) |
| Yahoo Finance | IOVA Stock Heads For Worst Day In Over 17 Months, Retail Says ‘Selling Is Not Done’ – What’s Driving The Fall? | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxQU1YtM3FFYS1qMUVuN2xEY1VRMjljeVNrdTVuQTRJZjg5aDVaRmtJWTlFTnBQdUZfbndnS1ZlMEVpLV83dlN5VVUxSUV5VzRLN3NQcV9Pc01zVXd2RC03TGU3cFh4NFN6bEVDMk9pTjM5bkN2aWdQcnZkeXg3SDhkQWZ3T0RJMk1zOWs2aXFUbURhbzRrX3c?oc=5) |
| Investor's Business Daily | Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxQbjNYbm1RODUzTy12ZFJtQ0lKYm5yU3ZqSXItSENzRkdKVlVjeE9KdWpkNmYwRWlPVTFGbVp5bnczOE5CdWtiOVJhRVJ0LThOblFUUExqOF95OEU1TDVsZlBLNTFYZnRQMG00NUZkVDhrckZHNTh6TGs1RVp1QVRGZ2VUcWo?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-29/iovance-a-top-1-biotech-stock-crashes-in-a-surprise-lung-cancer-twist*